Match the $1 Million Lobular Breast Cancer Research Challenge Supporters Share Their “WHY?”
Thanks to the $1 Million gift made by Dr. Shannon Klingman, physician, lobular breast cancer survivor, and founder of Lume Deodorant, LBCA has launched a […]
LBCA SAB Member Dr. Jeselsohn Presents Keynote on ILC at the ESMO Breast Cancer Annual Congress
LBCA SAB Member, Dr. Rinath Jeselsohn gave a Keynote Lecture at the ESMO Breast Cancer annual congress in Berlin, Germany on May 5, 2026, “Lobular
LBCA is Making Waves for ILC Research
Since 2021, when LBCA issued the first grant solicitation for ILC research in history, LBCA has funded thirteen ILC focused research grants, and committed funding
LBCA is Making Waves for ILC Research Read More »
One Advocate’s Approach: How Julie Ray Is Leading the Way to Raise Awareness of ILC in the Carolinas
When Julie Ray was diagnosed with invasive lobular carcinoma in the summer of 2023, she had never heard that breast cancer had types. Three years
Advocacy in Action: LBCA Advocates Attend Living Beyond Breast Cancer 2026
LBCA was recently privileged to to share ILC information with patients and caregivers at Living Beyond Breast Cancer’s 2026 Conference on Metastatic Breast Cancer, which
Advocacy in Action: LBCA Advocates Attend Living Beyond Breast Cancer 2026 Read More »
Exciting Opportunity to Explore a Role on the LBCA Board of Directors
Members of the Lobular Breast Cancer Alliance community, I am Bob McDevitt, Chair of the LBCA Board of Directors, writing on behalf of the Board
Exciting Opportunity to Explore a Role on the LBCA Board of Directors Read More »
Amy Shares Her Story with Lobular Breast Cancer
I am Amy, a wife and mom living in Libby, MT. I enjoyed a 27-year career in digital marketing and now focus on breast cancer
Amy Shares Her Story with Lobular Breast Cancer Read More »
LBCA Wins 2026 Communicator Award for Nonprofit Social Media
We’re excited to share that LBCA has won a 2026 Communicator Award, Nonprofit Social media, level of distinction for the LBCA-Dr. Klingman Lobular Breast Cancer
LBCA Wins 2026 Communicator Award for Nonprofit Social Media Read More »
LBCA Thanks Community of Volunteers in Honor of Volunteer Appreciation Month
In honor of Volunteer Appreciation Month, we’re proud to recognize the extraordinary community of volunteers who help drive LBCA’s mission forward every day. From patient
LBCA Thanks Community of Volunteers in Honor of Volunteer Appreciation Month Read More »
Join us for the 2026 ILC Symposium this September in San Francisco, CA
Join us for the 2026 ILC Symposium this September 23 – 25 at the Hyatt Regency in San Francisco, CA LBCA is again proud to sponsor the
Join us for the 2026 ILC Symposium this September in San Francisco, CA Read More »
New ILC Clinical Trials Now Open
Participation in clinical trials is one way that patients who are affected by ILC can help advance the understanding of lobular breast disease. These are
New ILC Clinical Trials Now Open Read More »
New ILC Research Updates from LBCA’s Scientific Advisory Board Members
LBCA’s Scientific Advisory Board members have co-authored 10 new ILC specific studies so far this year. See the links below to read more about each
New ILC Research Updates from LBCA’s Scientific Advisory Board Members Read More »
Jules Shares Her Story with Lobular Breast Cancer
I was 52 and very athletic when I felt a swollen lymph node doing push-ups. It took weeks of imaging and biopsies to find out
Jules Shares Her Story with Lobular Breast Cancer Read More »
LBCA Travel Grant Scholarship Program – ILC Symposium Application
LBCA is offering a limited number of travel scholarship grants for patient advocates interested in Invasive Lobular Carcinoma (ILC) education and research advocacy to attend
LBCA Travel Grant Scholarship Program – ILC Symposium Application Read More »
8F FES-PET/MRI for Tailoring Treatment of Luminal a and Lobular Breast Cancer (FESTA) (NCT05982496)
Name of Trial/NCT#: 18F FES-PET/MRI for Tailoring Treatment of Luminal a and Lobular Breast Cancer (FESTA) (NCT05982496) Eligible patients: Women age ≥ 18 years with